Loading the latest PSX data…
Loading the latest PSX data…
AGP LimitedShariah-compliantKSE-100
−0.95 (−0.61%) today
Live, checked 0s agoThe AGP Limited share price was Rs 154.50 (−0.61%) at the last PSX update (Nov 17, 2026 2:07 PM). AGP is a pharmaceuticals stock in the KSE-100 index with a market value of Rs 43.3bn.
Last session's range16 Nov 2026
155.000% up the range157.10
52-week range
145.658% up the range258.67
Price limits (circuit breakers)
139.9147% up the range171.00
AGP ranks better than 50% of the 309 liquid PSX stocks we score. Each factor is a 0-100 rank (value is ranked half within pharmaceuticals). Education only, not a buy or sell signal.
−15.6% over 6M
Daily bars from PSX's end-of-day market summary; today's candle is provisional, from the live price (no volume until the close). Prices before a bonus issue, right issue or split are adjusted so the chart stays continuous; cash dividends are not taken out.
Full-screen AGP chart with levelsDownload AGP price history (CSV)Compare AGP with GLAXO
From daily closes to 2026-11-16. A description of the trend, not a forecast.
Trend reading
Downtrend
Down1 up · 5 down signalsUp
| S2 | S1 | Pivot | R1 | R2 |
|---|---|---|---|---|
| 153.75 | 154.60 | 155.85 | 156.70 | 157.95 |
+36.7% over 5 years
Monthly closing prices from the PSX Data Portal, since 2018.
| Announced | Period | Payout | Profit after tax | EPS (Rs) | Books close |
|---|---|---|---|---|---|
| 2 Nov 16:20 | 9 months to 30 Sept | None | – | 8.29 | – |
| 2 Nov 16:19 | 9 months to 30 Sept | None | Rs 1,190.5m | 4.28 | – |
| 24 Aug 16:09 | Half year to 30 Jun | None | – | 5.21 | – |
| 24 Aug 16:08 | Half year to 30 Jun | First interim cash dividend 20% | Rs 875.8m | 3.13 | 3 Sept – 4 Sept |
| 8 Jun 15:44 | – to – | None | – | – | 22 Jun – 29 Jun |
| 30 Apr 14:49 | 1st quarter to 31 Mar | None | – | 3.06 | – |
| 30 Apr 14:48 | 1st quarter to 31 Mar | None | Rs 556.9m | 1.99 | – |
| Measure | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Sales growth | +10.8% | +33.8% | +35.0% | – |
| Profit growth | +13.3% | +75.1% | −16.7% | – |
| EPS growth | +13.3% | +75.1% | −16.7% | – |
| Net margin | 11.5% | 11.2% | 8.6% | 13.9% |
| Measure | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 |
|---|---|---|---|---|
| Sales growth | −24.2% | – | – | – |
| Profit growth | −53.1% | – | – | – |
| EPS growth | −52.9% | – | – | – |
| Net margin | 7.4% | 8.5% | 10.3% | 12.0% |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Sales | Rs 20.5bn | Rs 18.5bn | Rs 13.9bn | Rs 10.3bn |
| Profit after tax | Rs 2.4bn | Rs 2.1bn | Rs 1.2bn | Rs 1.4bn |
| Earnings per share (Rs) | 8.43 | 7.44 | 4.25 | 5.10 |
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 |
|---|---|---|---|---|
| Sales | Rs 4.2bn | Rs 3.7bn | Rs 5.4bn | Rs 5.6bn |
| Profit after tax | Rs 315m | Rs 319m | Rs 557m | Rs 671m |
| Earnings per share (Rs) | 1.13 | 1.14 | 1.99 | 2.40 |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Gross margin | 48.6% | 47.8% | 44.3% | 50.9% |
| Net margin | 11.5% | 11.2% | 8.6% | 13.9% |
| EPS growth | 13.3% | 75.1% | -16.7% | -8.8% |
| PEG | 1.81 | 0.30 | -0.99 | -1.45 |
Rupee amounts from PSX filings (thousands converted to Rs m/bn). Data by Capital Stake via the PSX Data Portal; standardised, so it can differ from the annual report. Latest quarter (Q3 2026) EPS fell 52.9% from the same quarter a year earlier.
| Measure | AGP | Sector median | Reading |
|---|---|---|---|
| P/E | 24.2 | 12.2 | Dearer than peers |
| Dividend yield | 5.1% | 4.9% | Above peers |
| Net margin | 11.5% | 8.8% | Above peers |
| EPS growth | +13.3% | +34.5% | Below peers |
| 1-year return | −16.6% | −12.0% | Below peers |
Sector P/E check. At the sector's median P/E of 12.2, last year's EPS of Rs 8.43 would price AGP at about Rs 102.56 (−34% from today). A rough yardstick only: sectors hold very different businesses, and the market prices future profits, not last year's.
Estimate a fair value for AGP (Graham, Lynch, DCF)AGP pivot levels
Ratios as published on the PSX Data Portal (standardised by Capital Stake), latest financial year on the right.
Work out your AGP dividend income after tax
| Announced | Period to | Payout | Cash per share | Books closed |
|---|---|---|---|---|
| 24 Aug 2026 | 30 Jun 2026 | First interim cash dividend 20% | Rs 2.00 | 3 Sept 2026 – 4 Sept 2026 |
PSX quotes payouts as a percentage of face value; cash per share assumes the usual Rs 10 face value. You get the dividend if you own the shares before the books close.
Market value
6th of 18
Rs 43.3bn
P/E (cheapest first)
13th of 13
24.2
Dividend yield
4th of 7
5.1%
1-year return
11th of 15
-16.6%
EPS growth
11th of 15
13.3%
Net margin
5th of 16
11.5%
danioPSX score
8th of 13
50/100
| GLAXOGlaxoSmithKline Pakistan Limited | Rs 106.7bn | −1.35% | 9.7 | 6.1% | −13.9% | 89 |
| ABOTAbbott Laboratories (Pakistan) Limited | Rs 98.3bn | +0.01% | 10.6 | 4.4% | −8.1% | 81 |
| HALEONHaleon Pakistan Limited | Rs 80.3bn | −0.56% | 12.3 | 3.6% | −15.7% | 67 |
| HINOONHighnoon Laboratories Limited | Rs 51.1bn | +0.86% | 12.4 | 5.4% | −15.4% | 76 |
| SEARLThe Searle Company Limited | Rs 46.7bn | −0.04% | 12.0 | – | −22.9% | 53 |
| AGPThis stock · AGP Limited | Rs 43.3bn | −0.61% | 24.2 | 5.1% | −16.6% | 50 |
| HPLHoechst Pakistan Limited | Rs 38.6bn | +0.15% | 11.0 | 6.9% | −2.5% | – |
| FEROZFerozsons Laboratories Limited | Rs 15.7bn | −1.07% | 22.8 | 1.6% | −8.8% | 39 |
| CPHLCiti Pharma Ltd. | Rs 14.5bn | +0.09% | 17.9 | – | −21.6% | 31 |
| GSKCHGlaxoSmithKline Consumer Healthcare | Rs 14.1bn | −3.13% | – | – | – | – |
| BFBIOBF Biosciences Limited | Rs 11.9bn | −0.67% | 18.2 | – | −10.1% | 44 |
| MACTERMacter International Limited | Rs 11.7bn | −1.51% | 3.6 | – | −28.2% | 51 |
| SAPLSanofi-Aventis Pakistan Limited | Rs 8.4bn | 0.00% | – | – | – | – |
| OTSUOtsuka Pakistan Limited | Rs 5.6bn | −1.01% | 11.4 | – | +35.9% | 65 |
| LIVENLiven Pharma Limited | Rs 5.4bn | +10.00% | – | – | −9.0% | 11 |
Swipe the table sideways for more columns.
No director or substantial-shareholder trades in AGP read from PSX notices yet.
Read automatically (OCR) from the disclosure images companies file with PSX under Regulation 5.6.1(d). A digit can be misread, so check the original notice before relying on a figure. Value = shares × price. Not investment advice. All PSX insider trades
AGP Limited was incorporated as a public limited company in May 2014 under the repealed Companies Ordinance, 1984 (now Companies Act, 2017). The Company got listed on Pakistan Stock Exchange Limited on 05 March 2018. The principal activities of the Company include import, marketing, export, dealership, distribution, wholesale and manufacturing of all kinds of pharmaceutical products. Aitkenstuart Pakistan (Private) Limited (parent company) holds 55.80% of the share capital of the Company and West End 16 Pte Limited, Singapore is the ultimate parent company.
Where the price sits in its 52-week range
Low 145.658% of the way upHigh 258.67
Data: PSX Data Portal (Nov 17, 2026 2:07 PM); company data refreshed 17 Nov; daily bars from PSX market summaries; five-year record from danioPSX research. Logos are trademarks of their owners. Not a recommendation to buy or sell AGP. Official PSX page for AGP